Brief: Astellas And Poseida Therapeutics Announce Strategic Investment To Support Poseida's Commitment To Redefining Cancer Cell Therapy

Poseida Therapeutics

07/08/2023 16:33

Aug 7 (Reuters) - Astellas Pharma Inc  4503.T :
    * ASTELLAS AND POSEIDA THERAPEUTICS ANNOUNCE STRATEGIC
INVESTMENT
TO SUPPORT POSEIDA'S COMMITMENT TO REDEFINING CANCER CELL
THERAPY
    * POSEIDA THERAPEUTICS INC - UNDER DEAL, ASTELLAS TO INVEST
A
TOTAL OF $50 MILLION TO ACQUIRE APPROXIMATELY 8.8% OF POSEIDA
    * POSEIDA THERAPEUTICS - UNDER DEAL, ASTELLA TO RECEIVE
RIGHT OF
EXCLUSIVE NEGOTIATION AND FIRST REFUSAL FOR ANY POTENTIAL
PARTNERING OF P-MUC1C-ALLO1
    * POSEIDA THERAPEUTICS INC - ASTELLAS WILL HAVE RIGHT TO
DESIGNATE
OBSERVER ON POSEIDA BOARD AND POSEIDA'S SCIENTIFIC ADVISORY
BOARD

Source text for Eikon:  ID:nPn5SWJsa 
Further company coverage:  4503.T